Exicure Inc
F:2H0
确定您愿意买入的价格,我们会帮您持续关注机会。
|
Exicure Inc
F:2H0
|
US |
|
E
|
Ebro Foods SA
SWB:AZU
|
ES |
|
China Minsheng Banking Corp Ltd
OTC:CMAKY
|
CN |
|
Heiwa Corp
F:HWC
|
JP |
|
Elemental Royalty Corp
F:A980
|
CA |
|
Time Finance PLC
F:B5D1
|
UK |
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
C
|
CECONOMY AG
F:CEC
|
DE |
|
S
|
Sellas Life Sciences Group Inc
F:RXK3
|
US |
|
Millicom International Cellular SA
F:M4M1
|
LU |
|
B
|
Biome Grow Inc
SWB:6OTA
|
CA |
|
C
|
Chugai Pharmaceutical Co Ltd
OTC:CHGCY
|
JP |
|
Tofutti Brands Inc
OTC:TOFB
|
US |
|
Lesaka Technologies Inc
NASDAQ:LSAK
|
ZA |
|
M
|
Merry Electronics Co Ltd
TWSE:2439
|
TW |
|
P
|
Park Systems Corp
KOSDAQ:140860
|
KR |
|
Orge Enerji Elektrik Taahhut AS
IST:ORGE.E
|
TR |
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
Illumina Inc
NASDAQ:ILMN
|
US |
|
Investors Title Co
NASDAQ:ITIC
|
US |
|
S
|
Subaru Corp
DUS:FUH
|
JP |
|
Global Dominion Access SA
MAD:DOM
|
ES |
|
Shimano Inc
F:SHM
|
JP |
|
A
|
Alset Ehome International Inc
NASDAQ:AEI
|
US |
基本面分析
Exicure 做什么
Exicure是一家生物技术公司,利用球形核酸(SNA)技术开发实验性药物。其核心工作是设计并测试候选药物,力求比传统药物更精准地开启或关闭基因,以治疗严重疾病。
- 总部
- 美国 US
- 员工人数
- 8
- 上市日期
- 2018年5月9日